This clinical quality registry aims to improve myeloma outcomes by providing an evidence base for the best strategies to diagnose, treat and support people with myeloma and related diseases.
Patients accrued
Patients with multiple myeloma
Number of approved sites
Biobank participants
MRDR-based FRAIL-M trial now has 10 sites & 10 patients recruited!
Read more$5.3 million funding over 5 years approved for APAC MRDR
Read more